Capitolis Advisors LLC Johnson & Johnson Transaction History

Capitolis Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$168.19 - $186.01 $270,113 - $298,732	-1,606 Reduced 0.32%	502,000 $89.1 Million
Q1 2022 May 12, 2022	SELL	$158.14 - $179.59 $38.1 Million - $43.3 Million	-241,131 Reduced 32.38%	503,606 $89.3 Million
Q4 2021 Feb 11, 2022	BUY	$155.93 - $173.01 $5.19 Million - $5.76 Million	33,286 Added 4.68%	744,737 $127 Million
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $11.6 Million - $12.9 Million	71,607 Added 11.19%	711,451 $114 Million
Q2 2021 Aug 11, 2021	BUY	$159.48 - $171.07 $34.1 Million - $36.5 Million	213,527 Added 50.09%	639,844 $105 Million
Q1 2021 May 13, 2021	SELL	$153.07 - $170.48 $35.9 Million - $40 Million	-234,635 Reduced 35.5%	426,317 $70.1 Million
Q4 2020 May 07, 2021	BUY	$137.11 - $157.38 $90.6 Million - $104 Million	660,952 New	660,952 $104 Million

4,227

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $410B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Capitolis Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Capitolis Advisors LLC with notifications on news.